Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMSG Amsurg (AMSG) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis Get Amsurg alerts: Email Address About Amsurg Stock (NASDAQ:AMSG) 30 days 90 days 365 days Advanced Chart Ad Behind the MarketsWARNING: “Buffett Indicator” flashing for first time in 50 yearsThe stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW Get Amsurg alerts:Sign Up Key Stats Today's Range$67.75▼$67.7550-Day Range N/A52-Week Range$57.32▼$84.71VolumeN/AAverage Volume1.03 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewEnvision Healthcare Corporation is a provider of healthcare services. The Company offers a range clinical solutions, including physician-led services, medical transportation, ambulatory services and post-acute services. The Company operates through three segments: physician services, medical transportation and ambulatory services. The physician services segment includes the Company's hospital-based and non-hospital-based physician services business. The medical transportation segment includes the Company's community-based medical transportation services, including emergency 911, non-emergency, managed transportation, air ambulance and disaster response services. The ambulatory services segment includes the Company's ambulatory surgery business, which acquires, develops, owns and operates ambulatory surgery centers (ASCs) and surgical hospitals in partnership with physicians and health systems.Read More… WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW Receive AMSG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amsurg and its competitors with MarketBeat's FREE daily newsletter. Email Address AMSG Stock News HeadlinesAnother Mega Health Care Deal: Blackstone Buys Back TeamHealthJune 17, 2023 | thestreet.comAmsurg Stock Hits New 52-Week High (AMSG)March 28, 2023 | thestreet.comHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.September 27, 2024 | Monument Traders Alliance (Ad)Why AmSurg (AMSG) Stock Is Higher This MorningSeptember 14, 2022 | thestreet.comEnvision Healthcare (EVHC) Stock Downgraded at OppenheimerSeptember 10, 2022 | thestreet.comSee More Headlines AMSG Stock Analysis - Frequently Asked Questions How were Amsurg's earnings last quarter? Amsurg Corp (NASDAQ:AMSG) released its quarterly earnings results on Tuesday, August, 2nd. The company reported $1.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.02. Amsurg's revenue for the quarter was up 21.5% on a year-over-year basis. What other stocks do shareholders of Amsurg own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amsurg investors own include Envision Healthcare (EVHC), Biogen (BIIB), CVS Health (CVS), NXP Semiconductors (NXPI), Broadcom (AVGO), Walt Disney (DIS) and Pediatrix Medical Group (MD). Company Calendar Last Earnings8/02/2016Today9/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Facilities Current SymbolNASDAQ:AMSG CUSIP03232P40 CIK895930 Webwww.amsurg.com Phone+1-615-6651283FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (NASDAQ:AMSG) was last updated on 9/27/2024 by MarketBeat.com Staff From Our PartnersThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | Sponsored10X More Profitable Than Physical Gold?The smart money is piling into gold and gold stocks. There's a backdoor gold play that could deliver 10 TIM...Monument Traders Alliance | SponsoredPrepare for an election day stock surpriseDuring his 50 years on Wall Street, legendary stockpicker Marc Chaikin traded through 13 presidential election...Chaikin Analytics | SponsoredBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredFed Triggers Boom: Buy this Play on Elon’s New AIHave you seen Elon Musk's new invention? I was already very bullish on this new type of AI. And now that...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amsurg Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Amsurg With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.